Show simple item record

AuthorAbouGalala, Khalid
AuthorElsayed, Basant
AuthorElmarasi, Mohamed
AuthorKotob, Mona
AuthorTaha, Reham
AuthorAbbasher, Fardous
AuthorAmarah, Ahmed
AuthorEl Hamawi, Mariam
AuthorAlbayat, Soha S.
AuthorAbdulmajeed, Jazeel
AuthorSallam, Mohamed A.H.
AuthorAl-Shamali, Maha H.M.
AuthorAl-Romaihi, Hamad E.
AuthorBansal, Devendra
AuthorMusa, Omran A.H.
AuthorFarag, Elmoubasher
AuthorAl-Thani, Mohammed H.J.
AuthorChivese, Tawanda
AuthorEmara, Mohamed M.
Available date2023-05-03T09:45:09Z
Publication Date2023-02-20
Publication NameMicrobiology Research
Identifierhttp://dx.doi.org/10.3390/microbiolres14010023
CitationAbouGalala, K., Elsayed, B., Elmarasi, M., Kotob, M., Taha, R., Abbasher, F., ... & Emara, M. M. (2023). Association between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study. Microbiology Research, 14(1), 289-296.
ISSN2036-7473
URIhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150946478&origin=inward
URIhttp://hdl.handle.net/10576/42274
AbstractThis study assessed the association between multimorbidity and mortality from COVID-19 in the Middle East and North Africa region, where such data are scarce. We conducted a cross-sectional study using data of all cases with COVID-19 reported to the Ministry of Public Health of Qatar from March to September 2020. Data on pre-existing comorbidities were collected using a questionnaire and multimorbidity was defined as having at least two comorbidities. Proportions of deaths were compared by comorbidity and multimorbidity status and multivariable logistic regression analyses were carried out. A total of 92,426 participants with a mean age of 37.0 years (SD 11.0) were included. Mortality due to COVID-19 was associated with gastrointestinal diseases (aOR 3.1, 95% CI 1.16–8.30), respiratory diseases (aOR 2.9, 95% CI 1.57–5.26), neurological diseases (aOR 2.6, 95% CI 1.19–5.54), diabetes (aOR 1.8, 95% CI 1.24–2.61), and CVD (aOR 1.5, 95% CI 1.03–2.22). COVID-19 mortality was strongly associated with increasing multimorbidity; one comorbidity (aOR 2.0, 95% CI 1.28–3.12), two comorbidities (aOR 2.8, 95% CI 1.79–4.38), three comorbidities (aOR 6.0, 95% 3.34–10.86) and four or more comorbidities (aOR 4.15, 95% 1.3–12.88). This study demonstrates a strong association between COVID-19 mortality and multimorbidity in Qatar.
Languageen
PublisherPagePress
Subjectchronic diseases
comorbidities
COVID-19
Middle East and North Africa
mortality
multimorbidity
pre-existing diseases
SARS-CoV-2
TitleAssociation between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study
TypeArticle
Pagination289-296
Issue Number1
Volume Number14
ESSN2036-7481
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record